Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on May 9, 2025
Minuteman Security & Life Safety Acquires Shanix Technology
EIN Presswire
·
May 9, 2025
ANDOVER, MA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Minuteman Security …
Justice Denied by Claudette Cupidon Reveals Legal Failures — Featured on the BrightWord Books Podcast
EIN Presswire
·
May 9, 2025
BOSTON, MA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- In an era where wrongful convictions and judicial corruption continue to make headlines, Claudette Cupidon's compelling new novel, Justice Denied: The Price of Ineffective Counsel, couldn’t be …
Creatio Outpaces Legacy CRMs by Being 37% More Cost-Efficient, 70% Faster, and Infinitely More Agile
EIN Presswire
·
May 9, 2025
Independent research confirms Creatio’s AI-native, no-code platform accelerates time-to-value, slashes costs, and gives businesses the freedom to adapt fast BOSTON, MA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Creatio, a global vendor of an AI- …
Creatio Names Praesto Consulting as Premier Partner, Advancing Strategic Growth Across the UK and North America
EIN Presswire
·
May 9, 2025
The collaboration aims to accelerate the adoption and growth of Creatio’s AI-powered no-code platform across the UK and North America BOSTON, MA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Creatio, a global vendor of an AI-native platform to …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
WOBURN, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired …
Just in Time for Mother's Day: FamilyWell’s Maternal Mental Health Program Now Accessible in Four States
GlobeNewswire
·
May 9, 2025
BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Available in Four States — Having already established a strong presence in Massachusetts and New Hampshire, FamilyWell Health is now extending its reach to Texas and Connecticut, two key states central to the …
Community Boating Awarded for Service to the Boston Community
GlobeNewswire
·
May 9, 2025
BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Community Boating, Inc. accepted two awards at the 2025 US Sailing Leadership Forum, a biannual conference for sailing leaders. CBI Executive Director Charlie Zechel received "The Marty” for his enduring …
Berman Tabacco Announces Investigation of Potential Securities Law Violations By Compass Diversified Holdings (CODI)
GlobeNewswire
·
May 9, 2025
BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI). About the Investigation On May 7, 2025, after the …
Cytel Partners with Nested Knowledge to Power the Next Generation of AI-Enhanced LiveSLR® for HEOR and HTA
GlobeNewswire
·
May 9, 2025
Cambridge, MA and St. Paul, MN, May 09, 2025 (GLOBE NEWSWIRE) -- Cytel, a global leader in evidence generation and data-driven decision-making, today announced a partnership with Nested Knowledge, a pioneer in AI-powered systematic literature review …
Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (“Garuda”), a biotechnology company developing off-the-shelf hematopoietic stem cell (HSC) therapies, today announced that it has changed its name to Stratus Therapeutics, Inc. (“ …
Anika Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
First Quarter 2025 Commercial Channel revenue up 18% Integrity™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating …
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
GlobeNewswire
·
May 9, 2025
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in …
Kymera Therapeutics Expands Industry Leading Immunology Pipeline with New First-in-Class, Oral IRF5 Degrader Program with Potential to Address Multiple Immuno-Inflammatory Diseases
GlobeNewswire
·
May 9, 2025
IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a historically undrugged transcription factor and master …
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33 …
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 9, 2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) new …
Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting
GlobeNewswire
·
May 9, 2025
First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with …
Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025
GlobeNewswire
·
May 9, 2025
Oral dual-targeted ABCB4/BSEP positive functional modulator (PFM) improved cholestatic and cholangitis markers in orthogonal models of hepatobiliary disease Data reinforce the potential of this differentiated mechanism of action (MOA) to address the core …
Imprivata ernennt Joel Burleson-Davis zum neuen Chief Technology Officer
GlobeNewswire
·
May 9, 2025
LANGENFELD, Germany, May 09, 2025 (GLOBE NEWSWIRE) -- Imprivata, das führende Unternehmen für digitale Identitäten in kritischen Branchen, wie dem Gesundheitswesen, hat Joel Burleson-Davis, seinen bisherigen Senior Vice President Engineering for …